Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Footnotes
  • Version history
  • Article usage
  • Citations to this article
Advertisement

Retraction Open Access | 10.1172/jci.insight.181492

Secondary bile acids mediate high-fat diet–induced upregulation of R-spondin 3 and intestinal epithelial proliferation

Ji-Yao Li, Merritt Gillilland III, Allen A. Lee, Xiaoyin Wu, Shi-Yi Zhou, and Chung Owyang

Find articles by Li, J. in: PubMed | Google Scholar

Find articles by Gillilland, M. in: PubMed | Google Scholar |

Find articles by Lee, A. in: PubMed | Google Scholar |

Find articles by Wu, X. in: PubMed | Google Scholar

Find articles by Zhou, S. in: PubMed | Google Scholar

Find articles by Owyang, C. in: PubMed | Google Scholar |

Published April 22, 2024 - More info

Published in Volume 9, Issue 11 on June 10, 2024
JCI Insight. 2024;9(11):e181492. https://doi.org/10.1172/jci.insight.181492.
© 2024 Li et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published April 22, 2024 - Version history
View PDF

Related article:

Secondary bile acids mediate high-fat diet–induced upregulation of R-spondin 3 and intestinal epithelial proliferation
Ji-Yao Li, Merritt Gillilland III, Allen A. Lee, Xiaoyin Wu, Shi-Yi Zhou, Chung Owyang
Ji-Yao Li, Merritt Gillilland III, Allen A. Lee, Xiaoyin Wu, Shi-Yi Zhou, Chung Owyang
Research Article Gastroenterology

Secondary bile acids mediate high-fat diet–induced upregulation of R-spondin 3 and intestinal epithelial proliferation

  • Text
  • PDF
Abstract

A high-fat diet (HFD) contributes to the increased incidence of colorectal cancer, but the mechanisms are unclear. We found that R-spondin 3 (Rspo3), a ligand for leucine-rich, repeat-containing GPCR 4 and 5 (LGR4 and LGR5), was the main subtype of R-spondins and was produced by myofibroblasts beneath the crypts in the intestine. HFD upregulated colonic Rspo3, LGR4, LGR5, and β-catenin gene expression in specific pathogen–free rodents, but not in germ-free mice, and the upregulations were prevented by the bile acid (BA) binder cholestyramine or antibiotic treatment, indicating mediation by both BA and gut microbiota. Cholestyramine or antibiotic treatments prevented HFD-induced enrichment of members of the Lachnospiraceae and Rumincoccaceae, which can transform primary BA into secondary BA. Oral administration of deoxycholic acid (DCA), or inoculation of a combination of the BA deconjugator Lactobacillus plantarum and 7α-dehydroxylase–containing Clostridium scindens with an HFD to germ-free mice increased serum DCA and colonic Rspo3 mRNA levels, indicating that formation of secondary BA by gut microbiota is responsible for HFD-induced upregulation of Rspo3. In primary myofibroblasts, DCA increased Rspo3 mRNA via TGR5. Finally, we showed that cholestyramine or conditional deletion of Rspo3 prevented HFD- or DCA-induced intestinal proliferation. We conclude that secondary BA is responsible for HFD-induced upregulation of Rspo3, which, in turn, mediates HFD-induced intestinal epithelial proliferation.

Authors

Ji-Yao Li, Merritt Gillilland III, Allen A. Lee, Xiaoyin Wu, Shi-Yi Zhou, Chung Owyang

×

Original citation JCI Insight. 2022;7(19):e148309. https://doi.org/10.1172/jci.insight.148309

Citation for this retraction: JCI Insight. 2024;9(11):e181492. https://doi.org/10.1172/jci.insight.181492

The University of Michigan recently notified JCI Insight that a research misconduct investigation committee found that there was falsification and/or fabrication of RT-PCR data in Figure 1C. In accordance with the institutional recommendation, JCI Insight is retracting this article.

Footnotes

See the related article at Secondary bile acids mediate high fat diet-induced upregulation of R-spondin 3 and intestinal epithelial proliferation.

Version history
  • Version 1 (April 22, 2024): Electronic publication
  • Version 2 (June 10, 2024): Electronic publication

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Footnotes
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts